Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01342393 · ClinicalTrials.gov registry record

Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Manifest Refraction and Autorefraction Results

A clinical trial of Refractive Error, sponsored by University of Nebraska.

Completed
Registry status
41
Enrollment target
1
Study location

NCT01342393 is a study of Refractive Error that has completed, run by University of Nebraska. The registered enrollment target is 41 participants, below the 609-participant average among 5 other Refractive Error trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01342393, a study of Refractive Error, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
41 participants
Enrollment target
1
Study location

Study Summary

Proof of concept study is to compare the best corrected visual acuity obtained via First-Sight lenses with the clinical "gold standard" of manifest refraction and autorefraction.

Conditions Studied

Study Locations (1)

Nebraska

  • University of Nebraska Medical Center, Department of Ophthalmology - Omaha

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2011-04
Est. Completion 2011-08

Sponsor

University of Nebraska

407 total trials

What the Registry Record Tells You About NCT01342393

The ClinicalTrials.gov registry entry for NCT01342393 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 5 other Refractive Error trials with a reported enrollment target (93% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Refractive Error appearing as the primary indexed condition, and to 0 interventions.

NCT01342393 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT01342393 about?

NCT01342393 is a clinical study titled "Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Manifest Refraction and Autorefraction Results". Proof of concept study is to compare the best corrected visual acuity obtained via First-Sight lenses with the clinical "gold standard" of manifest refraction and autorefraction.

What is the current status of trial NCT01342393?

This trial is currently completed. The enrollment target is 41 participants. The study started on 2011-04. Estimated completion is 2011-08.

What conditions does trial NCT01342393 study?

This clinical trial studies the following conditions: Refractive Error.

Who is sponsoring clinical trial NCT01342393?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01342393 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Refractive Error

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.